Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast
25 Ottobre 2023 - 10:15PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that the company has scheduled the release
of its third quarter 2023 financial results after the market closes
on Wednesday, November 1, 2023.
The Company will hold a conference call at 8:30 a.m. ET on
Thursday, November 2, which will be open to the public. During the
conference call, the company will review its financial results and
provide business updates.
Participants should register for, and access, the call using
this link. While not required, it is recommended to join 10 minutes
prior to the event start. Once registered, participants will be
given the option to either dial into the call with the number and
unique passcode provided, or to use the dial-out option to connect
their phone instantly. The link to access the live webcast can also
be found on the Sangamo Therapeutics website in the Investors and
Media section under Events.
A replay will be available following the conference call,
accessible under Events.
About Sangamo Therapeutics
Sangamo Therapeutics is a clinical-stage biopharmaceutical
company with a robust genomic medicines pipeline. Using
ground-breaking science, including our proprietary zinc finger
genome engineering technology and manufacturing expertise, Sangamo
aims to create new genomic medicines for patients suffering from
diseases for which existing treatment options are inadequate or
currently don’t exist. To learn more, visit www.sangamo.com and
connect with us on LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231025916590/en/
Investor & Media Inquiries
Louise Wilkie ir@sangamo.com media@sangamo.com
Grafico Azioni Sangamo Therapeutics (NASDAQ:SGMO)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Sangamo Therapeutics (NASDAQ:SGMO)
Storico
Da Mag 2023 a Mag 2024